IP Verse

Methods For Purifying Antibodies - EP2969098

The patent EP2969098 was granted to Glaxosmithkline on Oct 30, 2019. The application was originally filed on Mar 13, 2014 under application number EP14713926A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2969098

GLAXOSMITHKLINE
Application Number
EP14713926A
Filing Date
Mar 13, 2014
Status
Granted And Under Opposition
Sep 27, 2019
Grant Date
Oct 30, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WALLINGER RICKER SCHLOTTER TOSTMANNJul 30, 2020OETKE -

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0054951
DESCRIPTIONEP0239400
DESCRIPTIONUS2005043519
DESCRIPTIONWO0029004
INTERNATIONAL-SEARCH-REPORTWO2005082937
INTERNATIONAL-SEARCH-REPORTWO2007109163
OPPOSITIONWO2007109163
OPPOSITIONWO2014141150
OPPOSITIONWO2014186350

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- FRASER JOHN D ET AL, "The bacterial superantigen and superantigen-like proteins.", IMMUNOLOGICAL REVIEWS OCT 2008, (200810), vol. 225, doi:10.1111/j.1600-065X.2008.00681.x, ISSN 1600-065X, pages 226 - 243, XP055306250
OPPOSITION- Anonymous, "Albumin in Cell Culture", Sigma-Aldrich, (20081026), pages 1 - 2, XP055751730-
OPPOSITION- Anonymous, "Single Step Clarification & Capture of a Recombinant Protein from E. coli Osmotic Shock by Crossflow Chromatography", NATRIX, (20100000), pages 1 - 5, XP055751724-
OPPOSITION- ELIN MONIE, "Evaluation of the 96-well format for screening of chromatographic buffer conditions", Uptec X 03 030 Master's Degree Project, (20060000), pages 1 - 58, XP055495100-
OPPOSITION- Newcombe A R; Cresswell C; Davies S; Watson K; Harris G; O'Donovan K; Francis R, "Optimised affinity purification of polyclonal antibodies from hyper immunized ovine serum using synthetic Protein A adsorbent, MAbsorbenf A2P", Journal of Chromatography B, (20050000), vol. 814, no. 2, pages 209 - 215, XP027626838-
OPPOSITION- HAIOU YANG et al., "Purification of human immunoglobulin G via Fc-specific small peptide ligand affinity chromatography", Journal of Chromatography A, (20090000), vol. 1216, doi:10.1016/j.chroma.2008.12.004, pages 910 - 918, XP025872882
OPPOSITION- AMITH D. NAIK et al., "Performance of hexamer peptide ligands for affinity purification of immunoglobulin G from commercial cell culture media", Journal of Chromatography A, (20110000), vol. 1218, doi:10.1016/j.chroma.2010.11.071, pages 1691 - 1700, XP028175206
OPPOSITION- ZHUO LIU et al., "Effects of peptide density and elution pH on affinity chromatographic purification of human immunoglobulins A and M", Journal of Chromatography A, (20110000), vol. 1218, doi:10.1016/j.chroma.2011.09.038, pages 8344 - 8352, XP028325423
OPPOSITION- SUNIL CHHATRE et al., "Purification of antibodies using the synthetic affinity ligand absorbent MAbsorbent A2P", Nature Protocols, (20070000), vol. 2, no. 7, doi:10.1038/nprot.2007.253, pages 1763 - 1769, XP037115886
OPPOSITION- Sarah Le Merdy, "Selection of Clarification Methods for Improved Downstream Performance and Economics", BIOPROCESSING: ADVANCES AND TRENDS IN BIOLOGICAL PRODUCTDEVELOPMENT, US , (20151009), vol. 14, no. 3, doi:10.12665/J143.LeMerdy, ISSN 1538-8786, pages 50 - 55, XP055641737
OPPOSITION- Kevin A. Henry et al, "A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies", PLOS ONE, (20160915), vol. 11, no. 9, doi:10.1371/journal.pone.0163113, page e0163113, XP055471386

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents